Actovegin®: a biological drug for more than 5 decades

Wien Med Wochenschr. 2011 Feb;161(3-4):80-8. doi: 10.1007/s10354-011-0865-y.

Abstract

Actovegin(®) is a biological drug manufactured from a natural source: it is a calf blood hemodialysate. Its therapeutic benefits stem from a variety of pharmacodynamic actions that can be summarized to a common goal, i.e. the enhancement of cellular metabolism; this results from an insulin-like activity mediated by Inositol-phospho-oligosaccharides. Actovegin(®) results in beneficial effects in several pathophysiological clinical settings including malfunction of the blood circulation and trophic disturbances in the brain, impairment of peripheral blood circulation and associated diseases, dermal transplants and acute and chronic wounds. Here, we give an overview of the pharmacodynamic actions of calf-blood hemidialysate and its beneficial effects in a variety of clinical settings.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Products / pharmacokinetics
  • Biological Products / pharmacology*
  • Blood Glucose / metabolism
  • Drug Evaluation, Preclinical
  • Drugs, Investigational / pharmacokinetics
  • Drugs, Investigational / pharmacology*
  • Energy Metabolism / drug effects
  • Heme / analogs & derivatives*
  • Heme / pharmacokinetics
  • Heme / pharmacology
  • Humans
  • Hypoxia / blood
  • Oxygen Consumption / drug effects
  • Radiation-Protective Agents / pharmacokinetics
  • Radiation-Protective Agents / pharmacology
  • Wound Healing / drug effects

Substances

  • Biological Products
  • Blood Glucose
  • Drugs, Investigational
  • Radiation-Protective Agents
  • Heme
  • Actovegin